


Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma.
Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma. Durvalumab; deep learning; hypofractionated stereotactic re-irradiation; phase I clinical trial; recurrent glioblastoma; predictive...
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022 The Fonroga Foundation supports initiatives and achievements in the fields of culture and health in the Toulouse region. On 15 November 2022 it awarded several...
Welcome to the Brain Galaxy
Welcome to the Brain Galaxy Glioblastoma is a brain tumour whose aggressiveness can be attributed to tumour stem cells. Responsible for treatment resistance, these cells have the ability to form neurospheres and can engage in neural differentiation pathways under...
Study of the Interplay effect in Radiotherapy using Monte-Carlo methods.
Study of the Interplay effect in Radiotherapy using Monte-Carlo methods. Interplay Monte-Carlo Radiotherapy Bronchial cancers Contact : Luc Simon – t RADOPT : Optimising radiotherapy: from molecular signalling pathways to clinical trials. Radiotherapy of...